510(k) K040198— LABONE COCAINE METABOLITE MICRO-PLATE EIA

Substantially Equivalent

Labone, Inc.

Clearance details

Applicant: Labone, Inc.
Product code: Code DIO
Advisory panel: Clinical Toxicology
Date received: 2004-01-29
Decision date: 2004-03-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Lenexa, KS, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.